еНаука - преглед
Преглед према Аутор Sretenovic A
Приказ резултата 1 до 3 од 3
| Година | Наслов | Аутор(и) | Тип резултата | Мп-кат. |
|---|---|---|---|---|
| 2015 | Prediction tools for estimating the risk of TE - events in lymphoma patients have not been established but our newly developed - model should be used in addition to chemotherapy-associated model in - guiding best practice in the prevention of thromboembolism in patients living - with lymphoma | Antic D; Milic N; Todorovic M; Bila J; Andjelic B; Djurasinovic V; Sretenovic A; Vukovic V; Jelicic J; Nikolovski, Srđan  ;
Mihaljevic B;
| Научни чланак | 21aM21a - Рад у међ. часопису изузетних вредности |
| 2015 | The treatment of PCNSL still remains doubtful, however possible benefit from the TTR followed with HD-MTX with/without WBRT should be reconsidered | Stanisavljević, Dejana  ; Jelicic J; Todorovic Balint M; Raicevic S; Ilic R; Bila J; Antic D; Balint B; Andjelic B; Djurasinovic V;
Sretenovic A; Vukovic V; Mihaljevic B.;
| Научни чланак | 23M23 - Рад у међ. часопису |
| 2014 | Treatment of Multiple Myeloma in Patients Eligible for the Autologous Stem Cell Transplantation: Matter of Choice, Response and Efficacy | Vujić, Dragana ; Bila J; Jelicic J; Djurasinovic V; Antic D; Todorovic M; Sefer D; Kraguljac N; Bogunovic M; Andjelic B;
Vukovic V; Sretenovic A; Gotic M
; Elezovic I; Tomin D; Mihaljevic B ; | Конференцијски рад | Мп категорија ће бити приказана накнадно. |